← Back to Search

Topical Retinoid and Benzoyl Peroxide Combination

IDP-126 Gel for Acne

Phase 2
Waitlist Available
Research Sponsored by Bausch Health Americas, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male or female at least 12 years of age and older.
Subject must have an EGSS of 3 (moderate) or 4 (severe) at the baseline visit.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to week 12
Awards & highlights

Study Summary

This study is evaluating whether a gel containing a new medication may help treat acne.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Absolute change from Baseline to Week 12 in lesion counts.
Percentage of subjects who achieve at least a two-grade reduction from baseline and are "Clear" or "Almost Clear" at Week 12 in the Evaluator's Global Severity Score.

Side effects data

From 2021 Phase 3 trial • 183 Patients • NCT04214639
12%
Application site pain
7%
Erythema
100%
80%
60%
40%
20%
0%
Study treatment Arm
IDP-126 Gel
IDP-126 Vehicle Gel

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: IDP-126 GelExperimental Treatment1 Intervention
Group II: Epiduo® Forte GelActive Control1 Intervention
Group III: IDP-126 Vehicle GelPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
IDP-126 Gel
2020
Completed Phase 3
~1860

Find a Location

Who is running the clinical trial?

Bausch Health Americas, Inc.Lead Sponsor
262 Previous Clinical Trials
81,342 Total Patients Enrolled
7 Trials studying Acne
2,298 Patients Enrolled for Acne
Anya LoncaricStudy DirectorBausch Health Americas, Inc.
38 Previous Clinical Trials
20,003 Total Patients Enrolled
3 Trials studying Acne
88 Patients Enrolled for Acne
Varsha BhattStudy DirectorBausch Health Americas, Inc.
8 Previous Clinical Trials
353 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Texas
New York
How old are they?
18 - 65
What site did they apply to?
Bausch Site 132
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
~183 spots leftby Mar 2025